This segment focuses on the research, development, manufacturing, and commercialization of devices used in the treatment of cardiovascular diseases. Key products include coronary stents and related delivery systems, and balloon catheters and accessories. R&D activities are centered on improving stent technology, developing advanced catheter designs, and enhancing the biocompatibility of materials. Technologies employed include advanced materials science, precision engineering, and minimally invasive techniques. The segment addresses a wide range of conditions, including coronary artery disease and peripheral vascular disease, aiming to improve patient outcomes by reducing the need for invasive procedures and improving long-term health. MicroPort's market positioning is strong in China and expanding globally, with a focus on providing cost-effective and innovative solutions. Future opportunities include expansion into new markets and the development of next-generation cardiovascular devices. Regulatory and clinical aspects involve rigorous testing and adherence to international standards to ensure patient safety and efficacy. Partnerships and collaborations are key to accessing new technologies and expanding market reach.

The Orthopedics Devices segment is dedicated to the design, manufacture, and distribution of orthopedic implants and equipment. This includes reconstructive joints, spine and trauma products, and other professional implants. Research and development efforts focus on improving implant materials, enhancing surgical techniques, and developing patient-specific solutions. Technologies utilized include advanced materials, 3D printing, and computer-assisted surgery. The segment addresses conditions such as osteoarthritis, fractures, and spinal disorders, aiming to restore mobility and improve the quality of life for patients. MicroPort's market position is strengthened by its focus on innovation and its ability to offer a comprehensive range of orthopedic solutions. Future growth opportunities include expanding into emerging markets and developing advanced surgical robotics. Regulatory compliance and clinical trials are essential to ensure the safety and effectiveness of orthopedic devices. Partnerships with hospitals and surgeons are crucial for product development and market penetration.

This segment concentrates on the development, manufacturing, and marketing of devices for the treatment of neurovascular diseases. Products and services are provided for conditions such as cerebral aneurysms, intracranial atherosclerotic diseases, and carotid artery diseases. R&D activities focus on creating innovative devices for minimally invasive procedures, improving embolic protection, and enhancing the precision of neurosurgical interventions. Technologies include advanced catheter designs, embolic coils, and flow diverters. The segment aims to improve patient outcomes by reducing the risk of stroke and other neurological complications. MicroPort's market position is enhanced by its focus on innovation and its ability to offer a comprehensive range of neurovascular solutions. Future growth opportunities include expanding into emerging markets and developing advanced surgical robotics. Regulatory compliance and clinical trials are essential to ensure the safety and effectiveness of neurovascular devices. Partnerships with hospitals and neurosurgeons are crucial for product development and market penetration.

The Surgical Devices segment is dedicated to the research, development, manufacture, and sale of surgical devices. This includes a range of instruments and equipment used in various surgical procedures. R&D activities focus on improving surgical precision, minimizing invasiveness, and enhancing patient outcomes. Technologies employed include advanced materials, robotics, and imaging systems. The segment addresses a wide range of surgical needs across multiple specialties, aiming to improve patient recovery times and reduce complications. MicroPort's market position is strengthened by its focus on innovation and its ability to offer a comprehensive range of surgical solutions. Future growth opportunities include expanding into emerging markets and developing advanced surgical robotics. Regulatory compliance and clinical trials are essential to ensure the safety and effectiveness of surgical devices. Partnerships with hospitals and surgeons are crucial for product development and market penetration.